FDA Draft Guidance Would Require Abuse Deterrence For Generic Opioid Drugs

(March 25, 2016, 8:52 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on March 24 said it has issued a draft guidance that would require makers of generic opioid drugs to develop abuse-deterrent formulations....

Related Sections